Both in Biotechnology
Vir Biotechnology vs Vericel
Over the past year VIR returned +96.4% and VCEL returned +10.4%; their daily moves had a correlation of 0.25.
VIR +96.4% VCEL +10.4%Growth of $1, one year, split-adjusted
| Metric | VIR | VCEL |
|---|---|---|
| Price | $11.00 | $40.51 |
| Market cap | $1.86B | $2.07B |
| Today | −2.65% | +0.62% |
| 1 month | −1.5% | +0.9% |
| 6 months | +8.1% | +11.0% |
| Year to date | +82.4% | +12.5% |
| 1 year | +85.5% | +17.3% |
| Revenue growth (YoY) | +19582.5% | +22.5% |
| Gross margin | 100.0% | 72.8% |
| Net margin | 33.5% | 2.8% |
| P/E (TTM) | — | 85.6× |
| Price / sales | 6.1× | 6.8× |
| Net cash | $532.7M | $162.5M |
| Dividend yield | — | — |
| Volatility (60d) | 51.4% | 33.0% |
| Short % of float | 12.3% | 11.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).